Versor Investments LP Makes New $482,000 Investment in Revvity, Inc. (NYSE:RVTY)

Versor Investments LP purchased a new stake in Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,319 shares of the company's stock, valued at approximately $482,000.

A number of other institutional investors have also recently bought and sold shares of RVTY. Gladius Capital Management LP acquired a new stake in Revvity during the 3rd quarter valued at $32,000. Continuum Advisory LLC raised its position in Revvity by 2,972.7% during the third quarter. Continuum Advisory LLC now owns 338 shares of the company's stock valued at $43,000 after buying an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB lifted its stake in Revvity by 55.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after acquiring an additional 138 shares in the last quarter. Avior Wealth Management LLC boosted its position in Revvity by 7,980.0% during the 3rd quarter. Avior Wealth Management LLC now owns 404 shares of the company's stock worth $52,000 after acquiring an additional 399 shares during the period. Finally, Principal Securities Inc. boosted its position in Revvity by 54.9% during the 4th quarter. Principal Securities Inc. now owns 598 shares of the company's stock worth $67,000 after acquiring an additional 212 shares during the period. Hedge funds and other institutional investors own 86.65% of the company's stock.

Insider Activity

In related news, insider Joel S. Goldberg sold 15,170 shares of the business's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company's stock, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the sale, the insider now directly owns 19,652 shares of the company's stock, valued at approximately $2,295,550.12. This trade represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by company insiders.

Remove Ads

Revvity Stock Performance

Shares of RVTY stock traded up $2.55 during trading on Wednesday, reaching $111.81. The company had a trading volume of 1,173,052 shares, compared to its average volume of 924,925. The firm's 50 day simple moving average is $116.77 and its two-hundred day simple moving average is $118.29. Revvity, Inc. has a one year low of $97.32 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The company has a market capitalization of $13.43 billion, a PE ratio of 50.59, a PEG ratio of 3.82 and a beta of 1.03.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period last year, the business earned $1.25 EPS. Sell-side analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.25%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's dividend payout ratio (DPR) is 12.67%.

Analyst Upgrades and Downgrades

RVTY has been the topic of a number of research reports. Sanford C. Bernstein downgraded Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price on the stock. in a report on Friday, January 10th. KeyCorp upped their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Barclays lifted their target price on shares of Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Bank of America raised shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target on the stock in a research note on Friday, December 13th. Finally, TD Cowen lifted their price objective on Revvity from $141.00 to $144.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. Four equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $136.25.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.